Follow the people · Insider
Gwenn Hansen
Gwenn Hansen files insider transactions with the SEC as a chief scientific officer of Nurix Therapeutics (NRIX). We hold 7 disclosed purchases and sales filed since 1 December 2020, 5 of them in the last 90 days.
- Files forNRIX
- Disclosed buys and sells7 in all, 5 in the last 90 days
- Last disclosure1 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 30 November 2020 — 1 September 2026Chief Scientific Officer · Nurix Therapeutics (NRIX)197 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 1,452 shares of Nurix TherapeuticsSEC Form 41 September 2026Common Stock · traded 1 September 2026 · filed 1 September 2026
- ▼ sold on the open market 1,452 shares of Nurix TherapeuticsSEC Form 41 September 2026Common Stock · traded 1 September 2026 · filed 1 September 2026
- exercised options over 1,452 shares of Nurix Therapeutics (a derivative holding)SEC Form 41 September 2026Employee Stock Option (right to buy) · traded 1 September 2026 · filed 1 September 2026
- ▼ sold on the open market 1,500 shares of Nurix TherapeuticsSEC Form 45 August 2026Common Stock · traded 4 August 2026 · filed 5 August 2026
- ▼ sold on the open market 2,611 shares of Nurix TherapeuticsSEC Form 45 August 2026Common Stock · traded 4 August 2026 · filed 5 August 2026
- exercised options over 4,356 shares of Nurix TherapeuticsSEC Form 45 August 2026Common Stock · traded 5 August 2026 · filed 5 August 2026
- ▼ sold on the open market 4,356 shares of Nurix TherapeuticsSEC Form 45 August 2026Common Stock · traded 5 August 2026 · filed 5 August 2026
- exercised options over 4,356 shares of Nurix Therapeutics (a derivative holding)SEC Form 45 August 2026Employee Stock Option (right to buy) · traded 5 August 2026 · filed 5 August 2026
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 July 2026Common Stock · traded 30 July 2026 · filed 30 July 2026
- exercised options over 2,858 shares of Nurix TherapeuticsSEC Form 430 July 2026Common Stock · traded 30 July 2026 · filed 30 July 2026
- exercised options over 3,572 shares of Nurix TherapeuticsSEC Form 430 July 2026Common Stock · traded 30 July 2026 · filed 30 July 2026
- ▼ sold on the open market 3,847 shares of Nurix TherapeuticsSEC Form 430 July 2026Common Stock · traded 30 July 2026 · filed 30 July 2026
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2026Restricted Stock Units · traded 30 July 2026 · filed 30 July 2026
- exercised options over 2,858 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2026Restricted Stock Units · traded 30 July 2026 · filed 30 July 2026
- exercised options over 3,572 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2026Restricted Stock Units · traded 30 July 2026 · filed 30 July 2026
- ▼ sold on the open market 5,394 shares of Nurix TherapeuticsSEC Form 425 June 2026Common Stock · traded 25 June 2026 · filed 25 June 2026
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 April 2026Common Stock · traded 30 April 2026 · filed 30 April 2026
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 April 2026Common Stock · traded 30 April 2026 · filed 30 April 2026
- exercised options over 2,858 shares of Nurix TherapeuticsSEC Form 430 April 2026Common Stock · traded 30 April 2026 · filed 30 April 2026
- ▼ sold on the open market 3,214 shares of Nurix TherapeuticsSEC Form 430 April 2026Common Stock · traded 30 April 2026 · filed 30 April 2026
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 April 2026Restricted Stock Units · traded 30 April 2026 · filed 30 April 2026
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 April 2026Restricted Stock Units · traded 30 April 2026 · filed 30 April 2026
- exercised options over 2,858 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 April 2026Restricted Stock Units · traded 30 April 2026 · filed 30 April 2026
- was granted 93,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 410 February 2026Employee Stock Option (right to buy) · traded 10 February 2026 · filed 10 February 2026
- was granted 42,875 shares of Nurix Therapeutics (a derivative holding)SEC Form 410 February 2026Restricted Stock Units · traded 10 February 2026 · filed 10 February 2026
- was granted 93,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 410 February 2026Employee Stock Option (right to buy) · traded 10 February 2026 · filed 10 February 2026
- was granted 42,875 shares of Nurix Therapeutics (a derivative holding)SEC Form 410 February 2026Restricted Stock Units · traded 10 February 2026 · filed 10 February 2026
- exercised options over 31,333 shares of Nurix TherapeuticsSEC Form 43 February 2026Common Stock · traded 3 February 2026 · filed 3 February 2026
- exercised options over 31,333 shares of Nurix Therapeutics (a derivative holding)SEC Form 43 February 2026Employee Stock Option (right to buy) · traded 3 February 2026 · filed 3 February 2026
- exercised options over 31,333 shares of Nurix Therapeutics (a derivative holding)SEC Form 43 February 2026Employee Stock Option (right to buy) · traded 3 February 2026 · filed 3 February 2026
- exercised options over 31,333 shares of Nurix TherapeuticsSEC Form 43 February 2026Common Stock · traded 3 February 2026 · filed 3 February 2026
- exercised options over 3,207 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- exercised options over 2,859 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 30 January 2026 · filed 30 January 2026
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- exercised options over 3,207 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 30 January 2026 · filed 30 January 2026
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 30 January 2026 · filed 30 January 2026
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 30 January 2026 · filed 30 January 2026
- exercised options over 2,859 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 30 January 2026 · filed 30 January 2026
- exercised options over 2,859 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- ▼ sold on the open market 4,797 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- ▼ sold on the open market 98 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- exercised options over 3,207 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 30 January 2026 · filed 30 January 2026
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 30 January 2026 · filed 30 January 2026
- exercised options over 3,207 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- exercised options over 2,859 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- ▼ sold on the open market 4,797 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- ▼ sold on the open market 98 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 30 January 2026 · filed 30 January 2026
- exercised options over 3,207 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 October 2025Restricted Stock Units · traded 30 October 2025 · filed 30 October 2025
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 October 2025Restricted Stock Units · traded 30 October 2025 · filed 30 October 2025
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 October 2025Restricted Stock Units · traded 30 October 2025 · filed 30 October 2025
- exercised options over 2,858 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 October 2025Restricted Stock Units · traded 30 October 2025 · filed 30 October 2025
- exercised options over 3,207 shares of Nurix TherapeuticsSEC Form 430 October 2025Common Stock · traded 30 October 2025 · filed 30 October 2025
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 October 2025Common Stock · traded 30 October 2025 · filed 30 October 2025
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 October 2025Common Stock · traded 30 October 2025 · filed 30 October 2025
- exercised options over 2,858 shares of Nurix TherapeuticsSEC Form 430 October 2025Common Stock · traded 30 October 2025 · filed 30 October 2025
- ▼ sold on the open market 4,087 shares of Nurix TherapeuticsSEC Form 430 October 2025Common Stock · traded 30 October 2025 · filed 30 October 2025
- was granted 20,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 423 October 2025Restricted Stock Units · traded 14 October 2025 · filed 23 October 2025
- exercised options over 3,207 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2025Restricted Stock Units · traded 30 July 2025 · filed 30 July 2025
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2025Restricted Stock Units · traded 30 July 2025 · filed 30 July 2025
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2025Restricted Stock Units · traded 30 July 2025 · filed 30 July 2025
- exercised options over 2,858 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2025Restricted Stock Units · traded 30 July 2025 · filed 30 July 2025
- exercised options over 3,207 shares of Nurix TherapeuticsSEC Form 430 July 2025Common Stock · traded 30 July 2025 · filed 30 July 2025
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 July 2025Common Stock · traded 30 July 2025 · filed 30 July 2025
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 July 2025Common Stock · traded 30 July 2025 · filed 30 July 2025
- exercised options over 2,858 shares of Nurix TherapeuticsSEC Form 430 July 2025Common Stock · traded 30 July 2025 · filed 30 July 2025
- ▼ sold on the open market 4,308 shares of Nurix TherapeuticsSEC Form 430 July 2025Common Stock · traded 30 July 2025 · filed 30 July 2025
- exercised options over 3,206 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 April 2025Restricted Stock Units · traded 30 April 2025 · filed 30 April 2025
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 April 2025Restricted Stock Units · traded 30 April 2025 · filed 30 April 2025
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 April 2025Restricted Stock Units · traded 30 April 2025 · filed 30 April 2025
- exercised options over 3,206 shares of Nurix TherapeuticsSEC Form 430 April 2025Common Stock · traded 30 April 2025 · filed 30 April 2025
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 April 2025Common Stock · traded 30 April 2025 · filed 30 April 2025
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 April 2025Common Stock · traded 30 April 2025 · filed 30 April 2025
- ▼ sold on the open market 3,377 shares of Nurix TherapeuticsSEC Form 430 April 2025Common Stock · traded 30 April 2025 · filed 30 April 2025
- was granted 75,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 413 February 2025Employee Stock Option (right to buy) · traded 11 February 2025 · filed 13 February 2025
- was granted 34,300 shares of Nurix Therapeutics (a derivative holding)SEC Form 413 February 2025Restricted Stock Units · traded 11 February 2025 · filed 13 February 2025
- exercised options over 3,207 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2025Restricted Stock Units · traded 30 January 2025 · filed 30 January 2025
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2025Restricted Stock Units · traded 30 January 2025 · filed 30 January 2025
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2025Restricted Stock Units · traded 30 January 2025 · filed 30 January 2025
- exercised options over 3,207 shares of Nurix TherapeuticsSEC Form 430 January 2025Common Stock · traded 30 January 2025 · filed 30 January 2025
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 January 2025Common Stock · traded 30 January 2025 · filed 30 January 2025
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 January 2025Common Stock · traded 30 January 2025 · filed 30 January 2025
- ▼ sold on the open market 3,357 shares of Nurix TherapeuticsSEC Form 430 January 2025Common Stock · traded 30 January 2025 · filed 30 January 2025
- ▼ sold on the open market 333 shares of Nurix TherapeuticsSEC Form 430 January 2025Common Stock · traded 30 January 2025 · filed 30 January 2025
- exercised options over 3,207 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 October 2024Restricted Stock Units · traded 30 October 2024 · filed 30 October 2024
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 October 2024Restricted Stock Units · traded 30 October 2024 · filed 30 October 2024
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 October 2024Restricted Stock Units · traded 30 October 2024 · filed 30 October 2024
- exercised options over 3,207 shares of Nurix TherapeuticsSEC Form 430 October 2024Common Stock · traded 30 October 2024 · filed 30 October 2024
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 October 2024Common Stock · traded 30 October 2024 · filed 30 October 2024
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 October 2024Common Stock · traded 30 October 2024 · filed 30 October 2024
- ▼ sold on the open market 3,437 shares of Nurix TherapeuticsSEC Form 430 October 2024Common Stock · traded 30 October 2024 · filed 30 October 2024
- exercised options over 3,207 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2024Restricted Stock Units · traded 30 July 2024 · filed 30 July 2024
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2024Restricted Stock Units · traded 30 July 2024 · filed 30 July 2024
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2024Restricted Stock Units · traded 30 July 2024 · filed 30 July 2024
- exercised options over 3,207 shares of Nurix TherapeuticsSEC Form 430 July 2024Common Stock · traded 30 July 2024 · filed 30 July 2024
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 July 2024Common Stock · traded 30 July 2024 · filed 30 July 2024
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 July 2024Common Stock · traded 30 July 2024 · filed 30 July 2024
- ▼ sold on the open market 3,408 shares of Nurix TherapeuticsSEC Form 430 July 2024Common Stock · traded 30 July 2024 · filed 30 July 2024
- exercised options over 3,206 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 April 2024Restricted Stock Units · traded 30 April 2024 · filed 30 April 2024
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 April 2024Restricted Stock Units · traded 30 April 2024 · filed 30 April 2024
- exercised options over 3,206 shares of Nurix TherapeuticsSEC Form 430 April 2024Common Stock · traded 30 April 2024 · filed 30 April 2024
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 April 2024Common Stock · traded 30 April 2024 · filed 30 April 2024
- ▼ sold on the open market 2,007 shares of Nurix TherapeuticsSEC Form 430 April 2024Common Stock · traded 30 April 2024 · filed 30 April 2024
- was granted 150,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 415 February 2024Employee Stock Option (right to buy) · traded 13 February 2024 · filed 15 February 2024
- was granted 45,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 415 February 2024Restricted Stock Units · traded 13 February 2024 · filed 15 February 2024
- exercised options over 3,207 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2024Restricted Stock Units · traded 30 January 2024 · filed 30 January 2024
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2024Restricted Stock Units · traded 30 January 2024 · filed 30 January 2024
- exercised options over 3,207 shares of Nurix TherapeuticsSEC Form 430 January 2024Common Stock · traded 30 January 2024 · filed 30 January 2024
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 January 2024Common Stock · traded 30 January 2024 · filed 30 January 2024
- ▼ sold on the open market 2,334 shares of Nurix TherapeuticsSEC Form 430 January 2024Common Stock · traded 30 January 2024 · filed 30 January 2024
- exercised options over 3,207 shares of Nurix Therapeutics (a derivative holding)SEC Form 41 November 2023Restricted Stock Units · traded 30 October 2023 · filed 1 November 2023
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 41 November 2023Restricted Stock Units · traded 30 October 2023 · filed 1 November 2023
- exercised options over 3,207 shares of Nurix TherapeuticsSEC Form 41 November 2023Common Stock · traded 30 October 2023 · filed 1 November 2023
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 41 November 2023Common Stock · traded 30 October 2023 · filed 1 November 2023
- ▼ sold on the open market 1,633 shares of Nurix TherapeuticsSEC Form 41 November 2023Common Stock · traded 31 October 2023 · filed 1 November 2023
- exercised options over 3,207 shares of Nurix Therapeutics (a derivative holding)SEC Form 41 August 2023Restricted Stock Units · traded 30 July 2023 · filed 1 August 2023
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 41 August 2023Restricted Stock Units · traded 30 July 2023 · filed 1 August 2023
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.